Paul Y. Kim

Paul Y. Kim

Auto-generated profile, based on publicly available information

Paul Y. Kim

Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2018 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
SHSara J. Henderson
Sara J. Henderson
JWJeffrey I. Weitz
Jeffrey I. Weitz
PKPaul Y. Kim
Paul Y. Kim

28 February 2020 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
HMHunter B. Moore
Hunter B. Moore
SGSatoshi Gando
Satoshi Gando
TIToshiaki Iba
Toshiaki Iba
PKPaul Y. Kim
Paul Y. Kim
CYCalvin H. Yeh
Calvin H. Yeh
DFDisseminated Intravascular Coagulation For The Subcommittees On Fibrinolysis
Disseminated Intravascular Coagulation For The Subcommittees On Fibrinolysis

7 April 2021 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Open access
PDF file
GJGaneem K. Juneja
Ganeem K. Juneja
MCMatthew Castelo
Matthew Castelo
CYCalvin H. Yeh
Calvin H. Yeh
SCSamantha E. Cerroni
Samantha E. Cerroni
BHBettina E. Hansen
Bettina E. Hansen
CICOVID‐BEACONS investigators
COVID‐BEACONS investigators
Background Immunothrombosis and coagulopathy in the lung microvasculature may lead to lung injury and disease progression in COVID‐19. We aim to identify biomarkers of coagulation, endothelial function, and fibrinolysis that are associated with disease severity and may have prognostic potential. Methods We performed a single‐center prospective study of 14 adult COVID‐19(+) ICU patients who were age and sex‐matched to 14 COVID‐19(‐) ICU patients, and healthy controls. Daily blood draws, clinical data, and patient characteristics were collected. Baseline values for ten biomarkers of interest were compared between the three groups, and visualized using Fischer’s linear discriminant function. Linear repeated measures mixed models were used to screen biomarkers for associations with mortality. Selected biomarkers were further explored and entered into an unsupervised longitudinal clustering machine learning algorithm to identify trends and targets that may be used for future predictive modelling efforts. Results Elevated D‐dimer was the strongest contributor in distinguishing COVID‐19 status; however D‐dimer was not associated with survival. Variable selection identified clot lysis time, and antigen levels of soluble thrombomodulin (sTM), plasminogen activator inhibitor‐1 (PAI‐1), and plasminogen as biomarkers associated with death. Longitudinal multivariate k‐means clustering on these biomarkers alone identified two clusters of COVID‐19(+) patients – low (30%) and high (100%) mortality groups. Biomarker trajectories that characterized the high mortality cluster were higher clot lysis times (inhibited fibrinolysis), higher sTM and PAI‐1 levels, and lower plasminogen levels. Conclusions Longitudinal trajectories of clot lysis time, sTM, PAI‐1, and plasminogen may have predictive ability for mortality in COVID‐19.

21 December 2022 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
JTJecko Thachil
Jecko Thachil
CLColin Longstaff
Colin Longstaff
Emmanuel J FavaloroEmmanuel J Favaloro
Emmanuel J Favaloro
GLGiuseppe Lippi
Giuseppe Lippi
TUTetsumei Urano
Tetsumei Urano
PKPaul Y. Kim
Paul Y. Kim

14 January 2023 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
ZZZe Zheng
Ze Zheng
LMLiliya Mukhametova
Liliya Mukhametova
MBMichael B. Boffa
Michael B. Boffa
EMErnest E. Moore
Ernest E. Moore
AWAlisa S. Wolberg
Alisa S. Wolberg
PKPaul Y. Kim
Paul Y. Kim

5 September 2024 in Blood
Verified
Journal Article
Closed access
PDF file
ABAbigail Ballard-Kordeliski
Abigail Ballard-Kordeliski
RLRobert H. Lee
Robert H. Lee
EOEllen Clelia O'Shaughnessy
Ellen Clelia O'Shaughnessy
PKPaul Y. Kim
Paul Y. Kim
SJSummer R. Jones
Summer R. Jones
WBWolfgang Bergmeier
Wolfgang Bergmeier
Interplay between platelets, coagulation factors, endothelial cells (ECs), and fibrinolytic factors is necessary for effective hemostatic plug formation. This study describes a 4-dimensional (4D) imaging platform to visualize and quantify hemostatic plug components in mice with high spatiotemporal resolution. Fibrin accumulation after laser-induced vascular injury was observed at the platelet plug–EC interface, controlled by the antagonistic balance between fibrin generation and breakdown. We observed less fibrin accumulation in mice expressing low levels of tissue factor or F12−/−mice compared with controls, whereas increased fibrin accumulation, including on the vasculature adjacent to the platelet plug, was observed in plasminogen-deficient mice or wild-type mice treated with tranexamic acid. Phosphatidylserine (PS), a membrane lipid critical for the assembly of coagulation factors, was first detected at the platelet plug–EC interface, followed by exposure across the endothelium. Impaired PS exposure resulted in a significant reduction in fibrin accumulation in cyclophilin D−/−mice. Adoptive transfer studies demonstrated a key role for PS exposure on platelets, and to a lesser degree on ECs, in fibrin accumulation during hemostatic plug formation. Together, these studies suggest that (1) platelets are the functionally dominant procoagulant cellular surface, and (2) plasmin is critical for limiting fibrin accumulation at the site of a forming hemostatic plug.